PortfoliosLab logo

BriaCell Therapeutics Corp. (BCT.TO)

Equity · Currency in CAD · Last updated Mar 24, 2023

Share Price Chart

Loading data...


The chart shows the growth of CA$10,000 invested in BriaCell Therapeutics Corp. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly CA$307 for a total return of roughly -96.93%. All prices are adjusted for splits and dividends.

BCT.TO (BriaCell Therapeutics Corp.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BCT.TO

BriaCell Therapeutics Corp.


BriaCell Therapeutics Corp. had a return of 57.80% year-to-date (YTD) and -17.46% in the last 12 months. Over the past 10 years, BriaCell Therapeutics Corp. had an annualized return of -14.82%, while the S&P 500 had an annualized return of 6.51%, indicating that BriaCell Therapeutics Corp. did not perform as well as the benchmark.

1 month-5.96%-3.20%
6 months14.51%5.40%
1 year-17.46%-13.73%
5 years (annualized)-25.08%4.45%
10 years (annualized)-14.82%6.51%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current BriaCell Therapeutics Corp. Sharpe ratio is -0.17. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

BCT.TO (BriaCell Therapeutics Corp.)
Benchmark (^GSPC)

Dividend History

BriaCell Therapeutics Corp. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

BCT.TO (BriaCell Therapeutics Corp.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the BriaCell Therapeutics Corp.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the BriaCell Therapeutics Corp. is 99.40%, recorded on May 19, 2021. The portfolio has not recovered from it yet.



To Bottom


To Recover



-99.4%May 2, 20111942May 19, 2021
-83.33%Dec 4, 200696Apr 24, 2009218Oct 15, 2010314
-51.72%Oct 18, 201020Nov 15, 2010103Apr 29, 2011123
-9.09%Oct 20, 20061Oct 20, 20067Dec 1, 20068

Volatility Chart

Current BriaCell Therapeutics Corp. volatility is 64.83%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

BCT.TO (BriaCell Therapeutics Corp.)
Benchmark (^GSPC)